Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects.
在健康受试者中，阿达木单抗生物类似药（M923）与阿达木单抗（Humira）具有药代动力学等效性、可比安全性和免疫原性
期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.380
Hillson Jan, Mant Tim, Rosano Molly, Huntenburg Carolyn, Alai-Safar Mehrshid, Darne Siddhesh, Palmer Donna, Pavlova Borislava G, Doralt Jennifer, Reeve Russell, Goel Niti, Weilert Doris, Rhyne Paul W, Chance Kamali, Caminis John, Roach James, Ganguly Tanmoy
